Featured Research

from universities, journals, and other organizations

Global safety monitoring of HIV drugs is essential, says International Forum

Date:
July 5, 2011
Source:
Public Library of Science
Summary:
With increasing numbers of people worldwide -- five million in 2010 -- on antiretroviral drugs for the treatment of HIV, the International Forum for Collaborative HIV Research recommends that improved and sustained global drug safety monitoring, including monitoring for substandard products, drug diversion, inappropriate use and toxicity, is critical.

With increasing numbers of people worldwide -- 5 million in 2010 -- on antiretroviral drugs for the treatment of HIV, the International Forum for Collaborative HIV Research recommends that improved and sustained global drug safety monitoring, including monitoring for substandard products, drug diversion, inappropriate use, and toxicity, is critical.

Writing in this week's PLoS Medicine, the Forum reports on a meeting in which key stakeholders from the UN and government agencies, donors, industry, academia, multilateral organizations, and implementers discussed the creation of a sustainable global pharmacovigilance system for antiretroviral drugs.

While all participants claimed that they were dedicated to establishing global pharmacovigilance, important contrasting priorities and values among stakeholders, such as national sovereignty versus regional and international collaboration, confidentiality of safety data versus need for transparency and public access, and generic versus innovator antiretroviral manufacturers remain barriers to progress.

The Forum authors state: "Many stakeholders with substantial interests are still not routinely at the table. Most prominently, the pharmaceutical industry, both innovator and generic, are not included, although both sets of institutions have substantial investment in global infrastructure, personnel, data management, databases, and other resources that could be purposed, at least in part, to sustaining global pharmacovigilance systems in [resource-limited settings]."

The Forum concludes: "Recognition, understanding, and respect for these contrasts is a pathway for increased collaboration and cooperation that will then lead to a sustainable system involving all stakeholders including industry and experienced regulatory agencies."

Funding was provided by The Bill & Melinda Gates Foundation.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nyasha Bakare, Ivor Ralph Edwards, Andy Stergachis, Shanthi Pal, Charles B. Holmes, Marie Lindquist, Chris Duncombe, Alex Dodoo, Joel Novendstern, Jude Nwokike, Ricardo Kuchenbecker, Judith A. Aberg, Veronica Miller, Jur Strobos. Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. PLoS Medicine, 2011; 8 (7): e1001054 DOI: 10.1371/journal.pmed.1001054

Cite This Page:

Public Library of Science. "Global safety monitoring of HIV drugs is essential, says International Forum." ScienceDaily. ScienceDaily, 5 July 2011. <www.sciencedaily.com/releases/2011/07/110705183615.htm>.
Public Library of Science. (2011, July 5). Global safety monitoring of HIV drugs is essential, says International Forum. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2011/07/110705183615.htm
Public Library of Science. "Global safety monitoring of HIV drugs is essential, says International Forum." ScienceDaily. www.sciencedaily.com/releases/2011/07/110705183615.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins